Naveris Inc. is a molecular diagnostics company developing and commercializing novel blood and saliva tests to enhance the early detection and clinical management of viral-driven cancers. The company’s NavDx® blood test, which uses proprietary technology to detect tumor-tissue–modified HPV (TTMV®) DNA, is in use at leading medical centers.